

A Georgetown oncologist who now treats nearly half his colorectal cancer patients under 50 has created a revolutionary platform to speed up clinical trials.

KLEOS cuts years off the drug approval process for a disease that's become the deadliest cancer for younger Americans.

Want to know more?